System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Donia Bahloul is an expert in Dermatology at Sanofi (France) (France). Donia Bahloul has authored 36 publications, the most recent in 2026. SLR score: 137 (community average: 125). How the SLR is computed.

LeadR Profile

Donia Bahloul Sanofi (France) France
137 ScienceLeadR Reputation 137

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Public Health - Neurology - Psychology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2022 - 2026
Source: PubMed

Sanofi (France)

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 36

Citations

Citations: 24 1st author: 10 Last author: 10 Unique author: 0

Main journals

J Am Acad Dermatol 9
Value Health 6
Br J Dermatol 4
Dermatol Ther (Heidelb) 3
J Eur Acad Dermatol Venereol 3

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Standardizing Prurigo Control Assessment Globally: Linguistic Validation and Cross-cultural Adaptation of Prurigo Control Test in 18 Languages.
PMID 42403311 — language, physicians, prurigo, linguistics, dermatology		Acta Derm Venereol20260
Concept elicitation and development of a patient-centric conceptual disease model in chronic pruritus of unknown origin.
PMID 42274934 — skin, sleep, signs and symptoms, pruritus, patient reported outcome measures, research		J Patient Rep Outcomes20260
Dupilumab Improves Prurigo Activity and Severity in Patients with Prurigo Nodularis: A Post Hoc Analysis of Pooled Results from the PRIME and PRIME2 Trials.
PMID 41922877 — prurigo, wounds and injuries		Dermatol Ther (Heidelb)20260
Dupilumab Improves Daily Symptom Burden in Adult Patients with Prurigo Nodularis: Post Hoc Analysis from LIBERTY PN-PRIME and PRIME2 Studies.
PMID 41772282 — skin, pain, sleep, respect, signs and symptoms, pruritus, prurigo, therapeutics		Dermatol Ther (Heidelb)20260
Prurigo Nodularis paTient Reported burdEn of sicKness in Europe (PN TREK Europe): a cross-sectional survey of patient-reported burden of disease in patients with PN from four countries in Europe.
PMID 41702851 — skin, quality of life, cross-sectional studies, signs and symptoms, prurigo, cost of illness, therapeutics		J Dermatolog Treat20260

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS